Document Detail


Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
MedLine Citation:
PMID:  23149705     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Primary cutaneous B-cell lymphoma (PCBCL) is an heterogeneous group of lymphoproliferative disorders, which account for 25-30% of all primary cutaneous lymphoma and include three main histotypes: 1) primary cutaneous marginal zone B-cell lymphoma (PCMZL); 2) primary cutaneous follicular center cell lymphoma (PCFCL); 3) primary cutaneous diffuse large B-cell lymphoma (DLBCL), leg type (PCDLBCL-LT). PCMZL and PCFCL are indolent lymphomas, with an excellent prognosis despite an high rate of cutaneous recurrences; in contrast, PCDLBCL-LT is clinically more aggressive and usually requires to be treated with multi-agent chemotherapy and anti-CD20 monoclonal antibodies. PCDLBCL-LT histologically consists of large round cells (centroblasts and immunoblasts), is characterized by strong bcl-2 expression, in the absence of t(14;18) translocation, and resembles the activated B-cell type of nodal DLBCL. Recently, the term primary cutaneous DLBCL-other (PCDLBCL-O) has been proposed to include diffuse lymphomas composed of large transformed B-cells that lack the typical features of PCDLBCL-LT and do not conform to the definition of PCFCL. Some clinical studies suggested that such cases have an indolent clinical course and may be treated in a conservative manner; however, data regarding the actual prognosis and clinical behaviour of these peculiar cases are still too limited. The spectrum of primary cutaneous DLBCL also encompasses some rare morphological variants, such as anaplastic or plasmablastic subtypes and T-cell rich B-cell lymphoma, and some recently described, exceedingly rare DLBCL subtypes, such as intravascular large B-cell lymphoma and EBV-associated large B-cell lymphoma of the elderly, which often present in the skin.
Authors:
M Paulli; M Lucioni; A Maffi; G A Croci; M Nicola; E Berti
Related Documents :
24222505 - Nonviral delivery for reprogramming to pluripotency and differentiation.
24217815 - Phenotypic variations of cartilage hair hypoplasia: granulomatous skin inflammation and...
23625115 - Targeting oncogene expression to endothelial cells induces proliferation of the myelo-e...
24567935 - The effects of exendine-4 on insulin producing cell differentiation from rat bone marro...
2578515 - Investigations into the nature of igh-v region-restricted t cell interactions by using ...
7923905 - Cd4+ t cell-targeted immunomodulation and the therapy of allergic disease.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia     Volume:  147     ISSN:  0392-0488     ISO Abbreviation:  G Ital Dermatol Venereol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102852     Medline TA:  G Ital Dermatol Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  589-602     Citation Subset:  -    
Affiliation:
Anatomic Pathology Section, Department of Molecular Pathology, University of Pavia and IRCCSFondazione Policlinico "San Matteo", Pavia, Italy - marco.paulli@unipv.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.
Next Document:  Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary.